Platform
NVIDIA and Eli Lilly Announce $1 Billion AI Co-Innovation Lab to Reinvent Drug Discovery
NVIDIA and Eli Lilly announced a $1 billion AI co-innovation lab in South San Francisco, combining Lilly's pharmaceutical expertise with NVIDIA's BioNeMo platform and Blackwell-powered supercomputing to reinvent drug discovery.
·2 min